Inventor
JUNG MIRA
US13 patents
⚠️ This page may combine multiple inventors who share the name “JUNG MIRA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHUTTLE PHARMACEUTICALS INC
8 patentsUS12077515B2Sep 3, 2024
Selective histone deacetylase inhibitors for the treatment of human disease
SHUTTLE PHARMACEUTICALS INC0 citations60
US11407723B2Aug 9, 2022
Selective histone deacetylase inhibitors for the treatment of human disease
SHUTTLE PHARMACEUTICALS INC0 citations60
US12357650B2Jul 15, 2025
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation
SHUTTLE PHARMACEUTICALS INC0 citations57
US11654157B2May 23, 2023
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation
SHUTTLE PHARMACEUTICALS INC0 citations57
US11584733B2Feb 21, 2023
Selective histone deacetylase inhibitors for the treatment of human disease
SHUTTLE PHARMACEUTICALS INC0 citations49
US11034667B2Jun 15, 2021
Selective histone deacetylase inhibitors for the treatment of human disease
SHUTTLE PHARMACEUTICALS INC0 citations49
US10745352B2Aug 18, 2020
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
SHUTTLE PHARMACEUTICALS INC0 citations49
US10730834B2Aug 4, 2020
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
SHUTTLE PHARMACEUTICALS INC0 citations49
KOZIKOWSKI ALAN P
3 patentsUS8748463B2Jun 10, 2014
Histone deacetylase inhibitors and methods of use thereof
KOZIKOWSKI ALAN P6 citations82
US8222451B2Jul 17, 2012
Histone deacetylase inhibitors and methods of use thereof
KOZIKOWSKI ALAN P9 citations82
US8653278B2Feb 18, 2014
Isoform selective HDAC inhibitors
KOZIKOWSKI ALAN P5 citations69